The University of Chicago Header Logo

Connection

Benjamin Derman to Recurrence

Back to Details
This is a "connection" page, showing publications Benjamin Derman has written about Recurrence.
Benjamin Derman
Connection Strength
0.047
Recurrence
  1. Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma. Sci Transl Med. 2026 May 27; 18(851):eadx1799.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.